These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 37006709)

  • 1. A Retrospective Modeling Study of the Targeted Non-Pharmaceutical Interventions During the Xinfadi Outbreak in the Early Stage of the COVID-19 Pandemic - Beijing, China, 2020.
    Wang Y; Sun K; Pan Y; Yi L; Huo D; Wu Y; Dong S; Guo J; Dou X; Wang W; Wu S; Bai X; Yu H; Wang Q
    China CDC Wkly; 2023 Feb; 5(5):108-112. PubMed ID: 37006709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 containment was achievable during the early stage of the pandemic: a retrospective modelling study of the Xinfadi outbreak in Beijing.
    Wang Y; Sun K; Pan Y; Yi L; Huo D; Wu Y; Dong S; Guo J; Dou X; Wang W; Wu S; Bai X; Yu H; Wang Q
    medRxiv; 2022 Sep; ():. PubMed ID: 36263065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronavirus disease 2019 outbreak in Beijing's Xinfadi Market, China: a modeling study to inform future resurgence response.
    Wang XL; Lin X; Yang P; Wu ZY; Li G; McGoogan JM; Jiao ZT; He XJ; Li SQ; Shi HH; Wang JY; Lai SJ; Huang C; Wang QY
    Infect Dis Poverty; 2021 May; 10(1):62. PubMed ID: 33962683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transmission dynamics and the effects of non-pharmaceutical interventions in the COVID-19 outbreak resurged in Beijing, China: a descriptive and modelling study.
    Cui X; Zhao L; Zhou Y; Lin X; Ye R; Ma K; Jiang JF; Jiang B; Xiong Z; Shi H; Wang J; Jia N; Cao W
    BMJ Open; 2021 Sep; 11(9):e047227. PubMed ID: 34493510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiological characteristics and transmission dynamics of the outbreak caused by the SARS-CoV-2 Omicron variant in Shanghai, China: a descriptive study.
    Chen Z; Deng X; Fang L; Sun K; Wu Y; Che T; Zou J; Cai J; Liu H; Wang Y; Wang T; Tian Y; Zheng N; Yan X; Sun R; Xu X; Zhou X; Ge S; Liang Y; Yi L; Yang J; Zhang J; Ajelli M; Yu H
    medRxiv; 2022 Jun; ():. PubMed ID: 35765564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of non-pharmaceutical interventions on SARS-CoV-2 transmission across 130 countries and territories.
    Liu Y; Morgenstern C; Kelly J; Lowe R; ; Jit M
    BMC Med; 2021 Feb; 19(1):40. PubMed ID: 33541353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lifting non-pharmaceutical interventions following the COVID-19 pandemic - the quiet before the storm?
    Oh KB; Doherty TM; Vetter V; Bonanni P
    Expert Rev Vaccines; 2022 Nov; 21(11):1541-1553. PubMed ID: 36039786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors Associated with the Implementation of Non-Pharmaceutical Interventions for Reducing Coronavirus Disease 2019 (COVID-19): A Systematic Review.
    Regmi K; Lwin CM
    Int J Environ Res Public Health; 2021 Apr; 18(8):. PubMed ID: 33920613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non Pharmaceutical Interventions for Optimal Control of COVID-19.
    Zamir M; Shah Z; Nadeem F; Memood A; Alrabaiah H; Kumam P
    Comput Methods Programs Biomed; 2020 Nov; 196():105642. PubMed ID: 32688137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustainable targeted interventions to mitigate the COVID-19 pandemic: A big data-driven modeling study in Hong Kong.
    Zhou H; Zhang Q; Cao Z; Huang H; Dajun Zeng D
    Chaos; 2021 Oct; 31(10):101104. PubMed ID: 34717342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics and Containment of 74 Imported COVID-19 Outbreaks: Experiences, Lessons, and Implications - China, 2020-2021.
    Li F; Wei C; Li B; Lin T; Jiang Y; Liu D; Yang Z; Yang Z; Sha F; Tang J
    China CDC Wkly; 2022 Dec; 4(50):1131-1135. PubMed ID: 36751557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of non-pharmaceutical interventions and vaccination on COVID-19 outbreaks in Nunavut, Canada: a Canadian Immunization Research Network (CIRN) study.
    Vilches TN; Abdollahi E; Cipriano LE; Haworth-Brockman M; Keynan Y; Sheffield H; Langley JM; Moghadas SM
    BMC Public Health; 2022 May; 22(1):1042. PubMed ID: 35614429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling the evolution of SARS-CoV-2 under non-pharmaceutical interventions and testing.
    Gurevich Y; Ram Y; Hadany L
    Evol Med Public Health; 2022; 10(1):179-188. PubMed ID: 35498119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contact tracing-induced Allee effect in disease dynamics.
    Arim M; Herrera-Esposito D; Bermolen P; Cabana Á; Inés Fariello M; Lima M; Romero H
    J Theor Biol; 2022 Jun; 542():111109. PubMed ID: 35346665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long, thin transmission chains of Severe Acute Respiratory Syndrome Coronavirus 2 may go undetected for several weeks at low to moderate reproduction numbers: Implications for containment and elimination strategy.
    Killeen GF; Kearney PM; Perry IJ; Conroy N
    Infect Dis Model; 2021; 6():474-489. PubMed ID: 33644500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Travel-related control measures to contain the COVID-19 pandemic: a rapid review.
    Burns J; Movsisyan A; Stratil JM; Coenen M; Emmert-Fees KM; Geffert K; Hoffmann S; Horstick O; Laxy M; Pfadenhauer LM; von Philipsborn P; Sell K; Voss S; Rehfuess E
    Cochrane Database Syst Rev; 2020 Oct; 10():CD013717. PubMed ID: 33502002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of non-pharmaceutical interventions for containing the COVID-19 outbreak in China.
    Lai S; Ruktanonchai NW; Zhou L; Prosper O; Luo W; Floyd JR; Wesolowski A; Santillana M; Zhang C; Du X; Yu H; Tatem AJ
    medRxiv; 2020 Mar; ():. PubMed ID: 32511601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiological characteristics and transmission dynamics of the outbreak caused by the SARS-CoV-2 Omicron variant in Shanghai, China: A descriptive study.
    Chen Z; Deng X; Fang L; Sun K; Wu Y; Che T; Zou J; Cai J; Liu H; Wang Y; Wang T; Tian Y; Zheng N; Yan X; Sun R; Xu X; Zhou X; Ge S; Liang Y; Yi L; Yang J; Zhang J; Ajelli M; Yu H
    Lancet Reg Health West Pac; 2022 Dec; 29():100592. PubMed ID: 36090701
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.